Boomi To Acquire Lunar.dev

Voyager Technologies to Acquire Astrobotic Technology for Up to $300 Million

June 7, 2026

Aerospace & Defense

Voyager Technologies signed a definitive agreement to acquire Astrobotic Technology, Inc., the Pittsburgh-based developer of commercial lunar delivery, lunar power (LunaGrid), and reusable rockets. The deal is valued at up to approximately $300 million (including contingent consideration payable in cash and stock) and is expected to close by early July 2026, subject to regulatory approvals. The acquisition is intended to accelerate Voyager’s Artemis-aligned “Moon Base” strategy by creating a full-stack lunar infrastructure platform, integrating Astrobotic capabilities such as the Peregrine and Griffin landers into Voyager’s lunar program.

MoonPay Acquires Dawn Labs

May 12, 2026

AI & Machine Learning

MoonPay, the crypto payments network, announced the acquisition of Dawn Labs, an applied AI research lab focused on AI and financial markets. The deal also includes the launch of Dawn CLI, an AI-native trading tool that converts plain-English strategy descriptions into autonomous trade execution.

Capacity Acquires Lang.ai

April 21, 2026

Cloud & SaaS

Capacity, an AI-powered support automation platform, announced it has acquired Lang.ai, a San Francisco-based AI analytics company focused on agentic LLM technology. The deal is intended to strengthen Capacity’s AI analytics and agentic capabilities across the customer experience journey.

OVHcloud to Acquire Dragon LLM

March 27, 2026

AI & Machine Learning

OVHcloud has signed a binding agreement to acquire Dragon LLM, a French developer of specialized generative AI models for regulated industries. The deal is intended to expand OVHcloud’s generative AI capabilities and support sovereign AI deployments both in the cloud and on-premises, alongside launching an OVHcloud AI lab focused on sovereign large language models.

Lunai Bioworks Acquires BBB Delivery Technology and CNS Alzheimer’s Drug Assets from the Clemann Group

March 26, 2026

Biotechnology

Lunai Bioworks executed a binding $20 million strategic transaction to acquire blood-brain barrier (BBB) delivery technology and CNS Alzheimer’s drug assets from the Clemann Group, SAS (or its assignee). The deal is structured as Series B Convertible Preferred with a fixed $1.50 conversion price and is intended to strengthen Lunai’s CNS Alzheimer's pipeline while enabling development across other CNS disorders.

JFrog Acquires Qwak AI to Add MLOps Capabilities

June 25, 2024

Cloud & SaaS

JFrog Ltd. has entered into a definitive agreement to acquire Qwak AI Ltd., a provider of an all-in-one MLOps platform. The acquisition will integrate Qwak's model training, serving and monitoring capabilities into the JFrog Software Supply Chain Platform to provide unified DevOps, DevSecOps and MLOps functionality.